Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160,377,960
-
Total 13F shares
-
36,753,131
-
Share change
-
+401,199
-
Total reported value
-
$309,237,147
-
Price per share
-
$8.41
-
Number of holders
-
70
-
Value change
-
+$3,919,729
-
Number of buys
-
29
-
Number of sells
-
27
Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q3 2021
As of 30 Sep 2021 Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,753,131 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Candriam Luxembourg S.C.A., COMMODORE CAPITAL LP, Ally Bridge Group (NY) LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, Fairmount Funds Management LLC, and BVF INC/IL.
This table shows 70 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.